BRIEF published on 08/27/2024 at 08:05, 1 year 9 months ago Cairn Homes Plc : Transaction sur actions propres Rachat D'actions Euronext Dublin Maisons Cairn Courtiers En Valeurs Mobilières Goodbody Transaction Sur Actions
PRESS RELEASE published on 08/27/2024 at 08:00, 1 year 9 months ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announces the purchase of 75,000 of its ordinary shares, detailing prices and volumes, as part of its share buyback program Ordinary Shares Share Buyback Cairn Homes Plc Financial Announcement Transaction Details
BRIEF published on 08/26/2024 at 08:05, 1 year 10 months ago Cairn Homes Plc Announces Share Buyback Transactions London Stock Exchange Share Buyback Market Abuse Regulation Euronext Dublin Goodbody Stockbrokers
BRIEF published on 08/26/2024 at 08:05, 1 year 10 months ago Cairn Homes Plc annonce des opérations de rachat d'actions Rachat D'actions Euronext Dublin Bourse De Londres Réglementation Sur Les Abus De Marché Courtiers En Valeurs Mobilières Goodbody
PRESS RELEASE published on 08/26/2024 at 08:00, 1 year 10 months ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 100,000 of its ordinary shares on Euronext Dublin and the London Stock Exchange. The repurchased shares will be cancelled as part of the Company's share buyback program London Stock Exchange Ordinary Shares Share Buyback Program Cairn Homes Plc Euronext Dublin
BRIEF published on 08/23/2024 at 08:05, 1 year 10 months ago Cairn Homes Plc: Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Euronext Dublin Goodbody Stockbrokers
BRIEF published on 08/23/2024 at 08:05, 1 year 10 months ago Cairn Homes Plc : Transaction sur actions propres Rachat D'actions Euronext Dublin Actions Ordinaires Bourse De Londres Courtiers En Valeurs Mobilières Goodbody
PRESS RELEASE published on 08/23/2024 at 08:00, 1 year 10 months ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announces the repurchase and cancellation of 100,000 ordinary shares. Details of the transactions and the impact on total shares in issue provided London Stock Exchange Ordinary Shares Share Buyback Cairn Homes Plc Euronext Dublin
BRIEF published on 08/22/2024 at 17:26, 1 year 10 months ago Cairn Homes Plc Announces Date for 2024 Interim Results Financial Statements 2024 Investor Call Cairn Homes Interim Results
BRIEF published on 08/22/2024 at 17:26, 1 year 10 months ago Cairn Homes Plc annonce la date de publication des résultats intermédiaires de 2024 2024 États Financiers Appel Aux Investisseurs Maisons Cairn Résultats Intermédiaires
Published on 06/26/2026 at 14:05, 3 hours 41 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 3 hours 46 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 4 hours 46 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 17:05, 41 minutes ago NAKIKI SE Receives an Adverse Opinion on Its 2024 Financial Statements and Management Report
Published on 06/26/2026 at 17:00, 46 minutes ago Darwin AG Announces Results of the 2026 Annual General Meeting
Published on 06/26/2026 at 16:38, 1 hour 7 minutes ago Cairn Homes Plc: Notice of H1 2026 Trading Update
Published on 06/26/2026 at 15:30, 2 hours 15 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 2 hours 22 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 07:00, 10 hours 46 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 10 hours 46 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
